Agree, great IP PORTFOLIO and very experienced team of scientists with a leader ship.
It is very rare to find a CEO Who has experience with financial institutions (worked there) plus knows bio technology. We should not expect is going to be smooth ride as well.
I personally think we are in good hands. However this is not a blue chip company or close to that, It is 100% high risk and speculation.
Therefore, one must know their emotional and financial Risk tolerance prior investing in speculative stocks etc. and consult your financial advisor.
Market Data 
Markets 
AI
